SUSMED,Inc. (TYO:4263)

Japan · Delayed Price · Currency is JPY

469.00

-100.00 (-17.57%)

Aug 27, 2026, 12:44 PM JST

SUSMED,Inc. Financials Overview

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	497	497	462	342	530	316
Revenue Growth	7.58%	7.58%	35.09%	-35.47%	67.72%	174.78%
Gross Profit	479	479	450	330	522	305
Operating Income	-330	-330	-300	-365	-48	-230
Net Income	-382	-382	-298	-357	-50	-233
Earnings Per Share	-22.67	-22.67	-17.75	-21.39	-3.05	-15.87
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Digital Therapeutics Product	200	400	200	-	-
Digital Therapeutics Platform	142.58	130.65	116.87	115.49	34.89

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Net Cash (Debt)	3,698	3,698	4,398	4,846	5,048	4,904
Net Cash Growth	-15.92%	-15.92%	-9.25%	-4.00%	2.94%	201.60%
Net Cash Per Share	219.49	219.49	261.90	290.30	307.76	333.99
Cash & Investments	3,698	3,698	4,398	4,846	5,048	4,904

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-474	-474	-432	-230	100	-165
Capital Expenditures	-74	-74	-4	-3	-6	-12
Free Cash Flow	-548	-548	-436	-233	94	-177
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	96.38%	96.38%	97.40%	96.49%	98.49%	96.52%
Operating Margin	-66.40%	-66.40%	-64.94%	-106.73%	-9.06%	-72.78%
Pretax Margin	-76.26%	-76.26%	-64.29%	-104.09%	-9.25%	-73.73%
Profit Margin	-76.86%	-76.86%	-64.50%	-104.39%	-9.43%	-73.73%
FCF Margin	-110.26%	-110.26%	-94.37%	-68.13%	17.74%	-56.01%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 27, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
P/FCF Ratio	-	-	-	-	314.33	-
PS Ratio	19.25	29.33	22.24	29.37	55.75	46.54